4,060 research outputs found
Myogenic transcription factors regulate pro-metastatic miR-182
Approximately thirty percent of patients with soft-tissue sarcoma die from pulmonary metastases. The mechanisms that drive sarcoma metastasis are not well understood. Recently, we identified miR-182 as a driver of sarcoma metastasis in a primary mouse model of soft-tissue sarcoma. We also observed elevated miR-182 in a subset of primary human sarcomas that metastasized to the lungs. Here, we show that myogenic differentiation factors regulate miR-182 levels to contribute to metastasis in mouse models. We find that MyoD directly binds the miR-182 promoter to increase miR-182 expression. Furthermore, mechanistic studies revealed that Pax7 can promote sarcoma metastasis in vivo through MyoD-dependent regulation of pro-metastatic miR-182. Taken together, these results suggest that sarcoma metastasis can be partially controlled through Pax7/MyoD-dependent activation of miR-182 and provide insight into the role that myogenic transcription factors play in sarcoma progression
Efficacy of Phosphatidylinositol-3 Kinase Inhibitors in a Primary Mouse Model of Undifferentiated Pleomorphic Sarcoma
Recent advances in sarcoma genomics have identified novel mutations in the PI3K pathway in human sarcomas. Here, we use a mouse model of primary soft-tissue sarcoma for preclinical testing of doxorubicin and inhibitors of the PI3K pathway: BKM120 (PI3K inhibitor) and BEZ235 (a dual PI3K/mTOR inhibitor). Doxorubicin-treated tumors (n = 15) showed a partial response rate of 6.6%, just as the majority of human sarcomas do not respond to doxorubicin. Treatment with BKM120 elicited a partial response in 50% of tumors (n = 10), which was also seen in combination with doxorubicin (n = 10). Additionally, BKM120 treatment produced a robust delay in tumor growth kinetics. BEZ235-treated tumors (n = 9) showed a complete response rate of 11.1%. Combining BEZ235 with doxorubicin (n = 10) increased the complete response rate to 50% (P = 0.035). These studies demonstrate that PI3K pathway inhibition is a viable and attractive target for soft-tissue sarcomas
The risks of adverse events with venlafaxine and mirtazapine versus 'active placebo', placebo, or no intervention for adults with major depressive disorder: a protocol for two separate systematic reviews with meta-analysis and Trial Sequential Analysis
BACKGROUND: Major depressive disorder causes a great burden on patients and societies. Venlafaxine and mirtazapine are commonly prescribed as second-line treatment for patients with major depressive disorder worldwide. Previous systematic reviews have concluded that venlafaxine and mirtazapine reduce depressive symptoms, but the effects seem small and may not be important to the average patient. Moreover, previous reviews have not systematically assessed the occurrence of adverse events. Therefore, we aim to investigate the risks of adverse events with venlafaxine or mirtazapine versus 'active placebo', placebo, or no intervention for adults with major depressive disorder in two separate systematic reviews. METHODS: This is a protocol for two systematic reviews with meta-analysis and Trial Sequential Analysis. The assessments of the effects of venlafaxine or mirtazapine will be reported in two separate reviews. The protocol is reported as recommended by Preferred Reporting Items for Systematic Reviews and Meta-Analysis Protocols, risk of bias will be assessed with the Cochrane risk-of-bias tool version 2, clinical significance will be assessed using our eight-step procedure, and the certainty of the evidence will be assessed with the Grading of Recommendations Assessment, Development and Evaluation approach. We will search for published and unpublished trials in major medical databases and trial registers. Two review authors will independently screen the results from the literature searches, extract data, and assess risk of bias. We will include published or unpublished randomised clinical trial comparing venlafaxine or mirtazapine with 'active placebo', placebo, or no intervention for adults with major depressive disorder. The primary outcomes will be suicides or suicide attempts, serious adverse events, and non-serious adverse events. Exploratory outcomes will include depressive symptoms, quality of life, and individual adverse events. If feasible, we will assess the intervention effects using random-effects and fixed-effect meta-analyses. DISCUSSION: Venlafaxine and mirtazapine are frequently used as second-line treatment of major depressive disorder worldwide. There is a need for a thorough systematic review to provide the necessary background for weighing the benefits against the harms. This review will ultimately inform best practice in the treatment of major depressive disorder. SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD42022315395
Fast shape reconstruction of perfectly conducting cracks by using a multi-frequency topological derivative strategy
This paper concerns a fast, one-step iterative technique of imaging extended
perfectly conducting cracks with Dirichlet boundary condition. In order to
reconstruct the shape of cracks from scattered field data measured at the
boundary, we introduce a topological derivative-based electromagnetic imaging
function operated at several nonzero frequencies. The properties of the imaging
function are carefully analyzed for the configurations of both symmetric and
non-symmetric incident field directions. This analysis explains why the
application of incident fields with symmetric direction operated at multiple
frequencies guarantees a successful reconstruction. Various numerical
simulations with noise-corrupted data are conducted to assess the performance,
effectiveness, robustness, and limitations of the proposed technique.Comment: 17 pages, 27 figure
Weak coupling large-N transitions at finite baryon density
We study thermodynamics of free SU(N) gauge theory with a large number of
colours and flavours on a three-sphere, in the presence of a baryon number
chemical potential. Reducing the system to a holomorphic large-N matrix
integral, paying specific attention to theories with scalar flavours (squarks),
we identify novel third-order deconfining phase transitions as a function of
the chemical potential. These transitions in the complex large-N saddle point
configurations are interpreted as "melting" of baryons into (s)quarks. They are
triggered by the exponentially large (~ exp(N)) degeneracy of light baryon-like
states, which include ordinary baryons, adjoint-baryons and baryons made from
different spherical harmonics of flavour fields on the three-sphere. The phase
diagram of theories with scalar flavours terminates at a phase boundary where
baryon number diverges, representing the onset of Bose condensation of squarks.Comment: 38 pages, 7 figure
Thermodynamic analysis of the Quantum Critical behavior of Ce-lattice compounds
A systematic analysis of low temperature magnetic phase diagrams of Ce
compounds is performed in order to recognize the thermodynamic conditions to be
fulfilled by those systems to reach a quantum critical regime and,
alternatively, to identify other kinds of low temperature behaviors. Based on
specific heat () and entropy () results, three different types of
phase diagrams are recognized: i) with the entropy involved into the ordered
phase () decreasing proportionally to the ordering temperature
(), ii) those showing a transference of degrees of freedom from the
ordered phase to a non-magnetic component, with their jump
() vanishing at finite temperature, and iii) those ending in a
critical point at finite temperature because their do not decrease
with producing an entropy accumulation at low temperature.
Only those systems belonging to the first case, i.e. with as
, can be regarded as candidates for quantum critical behavior.
Their magnetic phase boundaries deviate from the classical negative curvature
below \,K, denouncing frequent misleading extrapolations down to
T=0. Different characteristic concentrations are recognized and analyzed for
Ce-ligand alloyed systems. Particularly, a pre-critical region is identified,
where the nature of the magnetic transition undergoes significant
modifications, with its discontinuity strongly
affected by magnetic field and showing an increasing remnant entropy at . Physical constraints arising from the third law at are discussed
and recognized from experimental results
A mechanism for the inhibition of DNA-PK-mediated DNA sensing by a virus
The innate immune system is critical in the response to infection by pathogens and it is activated by pattern recognition receptors (PRRs) binding to pathogen associated molecular patterns (PAMPs). During viral infection, the direct recognition of the viral nucleic acids, such as the genomes of DNA viruses, is very important for activation of innate immunity. Recently, DNA-dependent protein kinase (DNA-PK), a heterotrimeric complex consisting of the Ku70/Ku80 heterodimer and the catalytic subunit DNA-PKcs was identified as a cytoplasmic PRR for DNA that is important for the innate immune response to intracellular DNA and DNA virus infection. Here we show that vaccinia virus (VACV) has evolved to inhibit this function of DNA-PK by expression of a highly conserved protein called C16, which was known to contribute to virulence but by an unknown mechanism. Data presented show that C16 binds directly to the Ku heterodimer and thereby inhibits the innate immune response to DNA in fibroblasts, characterised by the decreased production of cytokines and chemokines. Mechanistically, C16 acts by blocking DNA-PK binding to DNA, which correlates with reduced DNA-PK-dependent DNA sensing. The C-terminal region of C16 is sufficient for binding Ku and this activity is conserved in the variola virus (VARV) orthologue of C16. In contrast, deletion of 5 amino acids in this domain is enough to knockout this function from the attenuated vaccine strain modified vaccinia virus Ankara (MVA). In vivo a VACV mutant lacking C16 induced higher levels of cytokines and chemokines early after infection compared to control viruses, confirming the role of this virulence factor in attenuating the innate immune response. Overall this study describes the inhibition of DNA-PK-dependent DNA sensing by a poxvirus protein, adding to the evidence that DNA-PK is a critical component of innate immunity to DNA viruses
Antidepressant Response in Major Depressive Disorder: A Meta-Regression Comparison of Randomized Controlled Trials and Observational Studies
To compare response to antidepressants between randomized controlled trials
(RCTs) and observational trials.Published and unpublished studies (from 1989 to 2009) were searched for by 2
reviewers on Medline, the Cochrane library, Embase, clinicaltrials.gov,
Current Controlled Trial, bibliographies and by mailing key organisations
and researchers. RCTs and observational studies on fluoxetine or venlafaxine
in first-line treatment for major depressive disorder reported in English,
French or Spanish language were included in the main analysis. Studies
including patients from a wider spectrum of depressive disorders (anxious
depression, minor depressive episode, dysthymia) were added in a second
analysis. The main outcome was the pre-/post-treatment difference on
depression scales standardised to 100 (17-item or 21-item Hamilton Rating
Scale for Depression or Montgomery and Åsberg Rating Scale) in each
study arm. A meta-regression was conducted to adjust the comparison between
observational studies and RCTs on treatment type, study characteristics and
average patient characteristics. 12 observational studies and 109 RCTs
involving 6757 and 11035 patients in 12 and 149 arms were included in the
main analysis. Meta-regression showed that the standardised treatment
response in RCTs is greater by a magnitude of 4.59 (2.61 to 6.56). Study
characteristics were related to standardised treatment response, positively
(study duration, number of follow-up assessments, outpatients versus
inpatients, per protocol analysis versus intention to treat analysis) or
negatively (blinded design, placebo design). At patient level, response
increased with baseline severity and decreased with age. Results of the
second analysis were consistent with this.Response to antidepressants is greater in RCTs than in observational studies.
Observational studies should be considered as a necessary complement to
RCTs
Interaction between expectancies and drug effects: an experimental investigation of placebo analgesia with caffeine as an active placebo
In a randomised placebo-controlled clinical trial it is assumed that psychosocial effects of the treatment, regression to the mean and spontaneous remission are identical in the drug and placebo group. Consequently, any difference between the groups can be ascribed to the pharmacological effects. Previous studies suggest that side effects of drugs can enhance expectancies of treatment effects in the drug group compared to the placebo group, and thereby increase placebo responses in the drug group compared to the
placebo group.
The hypothesis that side effects of drugs can
enhance expectancies and placebo responses was tested.
Painful laser stimuli were delivered to 20 healthy
subjects before and after administration of a drink with 0 or 4 mg/kg caffeine. The drink was administered either with information that it contained a painkiller or that it was a placebo. Laser-evoked potentials and reports of pain, expectancy, arousal and stress were measured.
Results Four milligrammes per kilogramme of caffeine reduced pain. Information that a painkiller was administered increased the analgesic effect of caffeine compared to caffeine administered with no drug information. This effect
was mediated by expectancies. Information and expectancies had no effect on pain intensity when 0 mg/kg was administered.
The analgesic effect of caffeine was increased by
information that a painkiller was administered. This was due to an interaction of the pharmacological action of the drug and expectancies. Hence, psychosocial effects accompanying a treatment can differ when an active drug is administered compared to a placebo
- …